Table 2 Demographic and clinical characteristics of responders and nonresponders before therapy

Age^a(years)

53.9 ± 7.7

53 ± 11.4

NS

Gender (M/F)

19/7

24/3

NS

Etiology of cirrhosis (viral hepatitis/others)

18/8

16/11

NS

Child–Pugh class (A/B/C)

3/7/16

1/7/19

NS

Child–Pugh score

9.8 ± 2.5

10.2 ± 2

NS

Ascites (±)

22/4

25/2

NS

Active bacterial infection (±)

8/18

7/20

NS

Serum total bilirubin^a (mg/dl)

2.6 ± 0.8

2.9 ± 0.8

NS

Serum albumin^a (g/dl)

2.6 ± 0.6

2.7 ± 0.5

NS

Serum creatinine^a (mg/dl)

1.9 ± 0.4

2.5 ± 1

<0.05

Serum Na^a (mEq/L)

129 ± 6

128 ± 4

NS

Urine volume^a (ml/day)

400 ± 186

285 ± 181

<0.05

MAP^a (mmHg)

80 ± 10

77 ± 9

NS